Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis

Abstract

ObjectivesThe aim of this study was to estimate the extra risk of second primary cancer among breast cancer patients.Methods and materialsThis is a systematic review. A comprehensive search of literature was performed in PubMed, Web of Science, Cochrane library, and Scopus. The search included all published studies up to October 2022. This systematic review included studies published in the English language that reported the risk of second primary non-breast cancer [i.e., standardized incidence ratio (SIR)] among breast cancer patients older than 15 years. After evaluating the methodological quality of the selected studies, SIRs were pooled with consideration of heterogeneity among studies. The estimates were pooled by age and time since the diagnosis of primary breast cancer for both sexes (male and female). Age was categorized based on before 50 years and after 50 years, and time was categorized as duration of less than and more than 10 years, respectively.ResultsFrom 2,484 articles, 30 articles were eligible for inclusion in the systematic review and meta-analysis. The studies varied in terms of population, number of cases, study design, setting, and year of implementation of the research. The estimated SIR for men and women was 1.28 (95% CI: 1.18, 1.38) and 1.27 (95% CI: 1.15, 1.39), respectively. Women diagnosed with breast cancer before menopause [SIR: 1.52 (95% CI: 1.34, 1.71) vs. 1.21 (95% CI: 1.08, 1.34)] as well as women after 10 years since their breast cancer diagnosis [1.33 (95% CI: 1.22, 1.431) vs. 1.24 (95% CI: 1.10, 1.37)] were at a higher risk of developing second primary cancer. Among men, while there were no differences in risk based on age, with the increase of time, the risk of second primary cancer was reduced [SIR: 1.22 (95% CI: 1.12, 1.33) vs. 1.00 (95% CI: 0.79, 1.22)].ConclusionThere is an extra risk of second primary cancer among breast cancer patients. The extra risk should be considered for further screening and preventive measures among this population.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?RecordID=336062, identifier (CRD42022336062).

Incidence and Characteristics of Multiple Primary Cancers: A 20-Year Retrospective Study of a Single Cancer Center in Korea

“…While our study did not assess cancer predisposition gene (CPG) status, the observed associations between first and second primary cancers suggest a potential role for CPG in contributing to the observed patterns. Ovarian cancer emerged as the most likely MPC among those with first primary breast cancer, supported by numerous studies and the established genetic link, especially in BRCA1/2 mutation carriers [32,33]. In line with other research, KCCH data revealed an increased risk of subsequent breast cancer after thyroid cancer.…”

The mechanism and therapeutic potential of lncRNA MIR497HG/miR-16-5p axis in breast cancer

“…With the increasing attention to the development of comprehensive treatment for breast cancer, the death toll of patients has declined in recent decades [ 16 ]. However, breast cancer is still the largest cancer afflicting women worldwide, with a negative situation [ 17 , 18 ].…”

Synchronous Occurrence of Triple-Negative Breast Cancer and Malignant Melanoma

“…Epidemiological studies suggest that following a breast cancer (BC) diagnosis among survivors at 5, 10, and 15 years, there is a 3.6%, 8.2% and 13.9% chance of acquiring another neoplasm, respectively [3].…”